FDA 483 - Pharmco Laboratories Inc. - September 22, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Pharmco Laboratories Inc. in Titusville, FL, was inspected and received a Form 483 with 10 observations, indicating significant deficiencies in their drug manufacturing operations. The inspection revealed widespread issues including inadequate equipment cleaning and maintenance, poor facility upkeep, insufficient process and water system validations, and failures in quality control. Additionally, problems were identified with laboratory controls and the proper management of drug product reserve samples.
ID · 8047a27a-811d-40be-8578-1acbe1e7ba66